An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation  by Serefoglu, Ege Can et al.
REVIEWS
An Evidence-Based Unified Definition of Lifelong and Acquired
Premature Ejaculation: Report of the Second International Society
for Sexual Medicine Ad Hoc Committee for the Definition of
Premature Ejaculation
Ege Can Serefoglu, MD,* Chris G. McMahon, MD,† Marcel D. Waldinger, MD, PhD,‡
Stanley E. Althof, PhD,§ Alan Shindel, MD,¶ Ganesh Adaikan, PhD,** Edgardo F. Becher, MD,††
John Dean, MD,‡‡ Francois Giuliano, MD, PhD,§§ Wayne J.G. Hellstrom, MD,¶¶
Annamaria Giraldi, MD, PhD,*** Sidney Glina, MD, PhD,††† Luca Incrocci, MD, PhD,‡‡‡
Emmanuele Jannini, MD,§§§ Marita McCabe, PhD,¶¶¶ Sharon Parish, MD,**** David Rowland, PhD,††††
R. Taylor Segraves, MD, PhD,‡‡‡‡ Ira Sharlip, MD,§§§§ and Luiz Otavio Torres, MD¶¶¶¶
*Department of Urology, Bagcilar Training & Research Hospital, Istanbul, Turkey; †Australian Center for Sexual Health,
Sydney, New South Wales, Australia; ‡Department of Pharmacology, Utrecht Institute of Pharmaceutical Sciences,
University of Utrecht, Utrecht, The Netherlands; §Department of Psychiatry, Case Western Reserve University School of
Medicine, West Palm Beach, FL, USA; ¶Department of Urology, University of California at Davis, Davis, CA, USA;
**Department of Obstetrics and Gynecology, National University of Singapore, Singapore; ††Division of Urology,
University of Buenos Aires, Buenos Aires, Argentina; ‡‡St. Peter’s Sexual Medicine Centre, The London Clinic, London,
UK; §§Neuro-Uro-Andrology Unit, Physical Medicine and Rehabilitation Department, Raymond Poincaré Hospital, Paris,
France; ¶¶Department of Urology, Tulane University Health Sciences Center, New Orleans, LA, USA; ***Department of
Sexological Research, Psychiatric Center Copenhagen, Rigshospitalet, Copenhagen, Denmark; †††Department of
Urology, Instituto H. Ellis, Sao Paulo, Brazil; ‡‡‡Erasmus MC–Daniel den Hoed Cancer Center, Rotterdam, The
Netherlands; §§§Endocrinology and Medical Sexology, Department of Experimental Medicine, University of L’Aquila,
L’Aquila, Italy; ¶¶¶School of Psychology, Deakin University, Melbourne, Victoria, Australia; ****Montefiore Medical Center,
Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA; ††††Graduate School, Valparaiso
University, Valparaiso, IN, USA; ‡‡‡‡Department of Psychiatry, Case Western Reserve University School of Medicine,
Cleveland, OH, USA; §§§§Department of Urology, University of California, San Francisco, CA, USA; ¶¶¶¶Clinica de
Urologia e Andrologia, Belo Horizonte, Minas Gerais, Brazil
DOI: 10.1002/sm2.27
A B S T R A C T
Introduction. The International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Deﬁnition of
Premature Ejaculation developed the ﬁrst evidence-based deﬁnition for lifelong premature ejaculation (PE) in 2007
and concluded that there were insufﬁcient published objective data at that time to develop a deﬁnition for acquired PE.
Aim. The aim of this article is to review and critique the current literature and develop a contemporary, evidence-
based deﬁnition for acquired PE and/or a uniﬁed deﬁnition for both lifelong and acquired PE.
Methods. In April 2013, the ISSM convened a second Ad Hoc Committee for the Deﬁnition of Premature
Ejaculation in Bangalore, India. The same evidence-based systematic approach to literature search, retrieval, and
evaluation used by the original committee was adopted.
Results. The committee unanimously agreed that men with lifelong and acquired PE appear to share the dimensions
of short ejaculatory latency, reduced or absent perceived ejaculatory control, and the presence of negative personal
consequences. Men with acquired PE are older, have higher incidences of erectile dysfunction, comorbid disease, and
cardiovascular risk factors, and have a longer intravaginal ejaculation latency time (IELT) as compared with men with
lifelong PE. A self-estimated or stopwatch IELT of 3 minutes was identiﬁed as a valid IELT cut-off for diagnosing
acquired PE. On this basis, the committee agreed on a uniﬁed deﬁnition of both acquired and lifelong PE as a male
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sexual dysfunction characterized by (i) ejaculation that always or nearly always occurs prior to or within about 1
minute of vaginal penetration from the ﬁrst sexual experience (lifelong PE) or a clinically signiﬁcant and bothersome
reduction in latency time, often to about 3 minutes or less (acquired PE); (ii) the inability to delay ejaculation on all
or nearly all vaginal penetrations; and (iii) negative personal consequences, such as distress, bother, frustration,
and/or the avoidance of sexual intimacy.
Conclusion. The ISSM uniﬁed deﬁnition of lifelong and acquired PE represents the ﬁrst evidence-based deﬁnition
for these conditions. This deﬁnition will enable researchers to design methodologically rigorous studies to improve
our understanding of acquired PE. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A,
Adaikan G, Becher EF, Dean J, Giuliano F, Hellstrom WJG, Giraldi A, Glina S, Incrocci L, Jannini E,
McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, and Torres LO. An evidence-based unified
definition of lifelong and acquired premature ejaculation: Report of the second International Society for
Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. Sex Med 2014;2:41–59.
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Introduction
Research into the treatment and epidemiologyof premature ejaculation (PE) is heavily
dependent on how PE is deﬁned. The medical
literature contains several univariate andmultivari-
ate operational deﬁnitions of PE [1–10]. Each of
these deﬁnitions characterizes men with PE using
all or most of the accepted dimensions of this con-
dition: ejaculatory latency, perceived ability to
control ejaculation, reduced sexual satisfaction,
personal distress, partner distress, and interper-
sonal or relationship distress. In the last decade,
substantial progress has been made in the develop-
ment of evidence-based methodology for epide-
miologic and drug treatment research on PE
through the use of objective (intravaginal ejacula-
tory latency time, IELT) and subjective (patient-
reported outcome, PRO) validated measures.
At one time, the deﬁnitions of PE given in the
American Psychiatric Association’s (APA’s) Diag-
nostic and Statistical Manual of Mental Disorders
(DSM) were largely accepted by the medical com-
munity with little discussion, despite having no
evidence-based medical support [11–13].
Following the introduction of evidence-based
PE pharmacotherapy, the validity of the DSM
deﬁnitions was the subject of debate, with a sub-
stantial polarization of opinion. The inclusion
of words such as “persistent,” “recurrent,”
“minimal,” and “shortly after” rendered the DSM
deﬁnitions vague, ambiguous, and lacking in
objective and quantitative criteria [14–16]. Con-
cerns about the validity and application of the
DSM-IV-TR deﬁnition were also expressed by
regulatory agencies such as the United States Food
and Drug Administration, which regarded the lack
of evidence-based criteria as an obstacle in inter-
pretation and assessment of data from clinical
trials of experimental drugs for PE.
The absence of a speciﬁc ejaculation time cutoff
point to operationalize “shortly after penetration
or before the person wishes” has led to ambiguous
application of the DSM criteria for PE in epide-
miological and clinical research [17–20]. Giuliano
et al. reported the IELT of men with DSM-IV-
TR-diagnosed PE to range from 0 seconds (ante
portas ejaculation) to almost 28 minutes, with 44%
of subjects having an IELT ≥2 minutes and 25%
≥4 minutes [20]. This study demonstrates that a
subject diagnosed with PE according to DSM-
IV-TR criteria has a 44% chance of not having PE
if a PE diagnostic threshold IELT of 2 minutes, as
suggested by community-based normative IELT
trial, is used [21].
Waldinger et al., in a number of studies in
cohorts of heterosexual men with lifelong PE
with prospective stopwatch IELT measurement,
showed that about 90% of men seeking treatment
for lifelong PE ejaculated within 1 minute after
penetration, and about 10% ejaculated between 1
and 2 minutes [17]. These data were conﬁrmed by
McMahon in a retrospective questionnaire analy-
sis of a large cohort of men with lifelong PE [22].
These data support the proposal that lifelong PE
is characterized by an IELT of less than or about
1 minute after vaginal penetration.
In October 2007, the International Society for
Sexual Medicine (ISSM) responded to these con-
cerns and convened a meeting in Amsterdam of the
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ISSM Ad Hoc Committee for the Deﬁnition of
Premature Ejaculation. The committee included
21 international experts in PE who were charged
with the development of the ﬁrst contempo-
rary, evidence-based deﬁnition of lifelong PE.
Evidence-based deﬁnitions seek to limit errors of
classiﬁcation and thereby increase the likelihood
that existing and newly-developed therapeutic
strategies are truly effective in carefully selected
dysfunctional populations [4]. After critical evalua-
tion of the published data, the committee unani-
mously agreed that the constructs that are
necessary to deﬁne lifelong PE are time from pen-
etration to ejaculation, inability to delay ejacula-
tion, and negative personal consequences from PE.
The following deﬁnition was agreed upon [10]:
Lifelong PE is a male sexual dysfunction characterized
by the presence of all of these criteria: (i) ejaculation
that always or nearly always occurs prior to or within
about 1 minute of vaginal penetration; (ii) the inability
to delay ejaculation on all or nearly all vaginal penetra-
tions; and (iii) negative personal consequences such as
distress, bother, frustration, and/or the avoidance of
sexual intimacy.
The committee was, however, unable to identify
sufﬁcient published objective data to craft an
evidence-based deﬁnition of acquired PE.
In April 2013, the International Society for
Sexual Medicine (ISSM) convened a second ISSM
Ad Hoc Committee for the Deﬁnition of Prema-
ture Ejaculation in Bangalore, India. The brief of
the committee was to evaluate the current pub-
lished data and attempt to develop a contempo-
rary, evidence-based deﬁnition of acquired PE
and/or a single unifying deﬁnition of both
acquired and lifelong PE.
This article chronicles the development of
current deﬁnitions of PE and details their
strengths and weaknesses. Included are critiques of
the evidence in support of the constructs of ejacu-
latory latency, ejaculatory control, sexual satisfac-
tion, and personal distress. The epidemiology,
etiology, and presenting symptoms of lifelong and
acquired PE are compared, and a new, unifying
deﬁnition for both acquired and lifelong PE is
proposed.
Definition Development Process
The second Ad Hoc ISSM Committee for the
Deﬁnition of Premature Ejaculation was sup-
ported by an unrestricted research grant from
Johnson & Johnson. However, ISSM required
complete independence from industry during the
development of the new deﬁnition of PE. There
were no industry representatives at the meeting,
and there was no attempt by industry to inﬂuence
any part of the development process at any time.
The same evidence-based systematic approach to
literature search, retrieval, and evaluation used in
the original meeting was adopted [23].
The Committee was chosen by peer recom-
mendation and comprised 19 experts appointed to
achieve a balance of opinion, knowledge, gender,
and geography. These 19 included several of the
world’s most highly recognized experts on PE and
comprised 6 psychologists or psychiatrists, 8
urologists, 2 sexual health physicians, 1 primary
care physician, 1 endocrinologist, and 1 radiation
oncologist. All of the attendees were ISSM
members. The meeting was organized, chaired,
and facilitated by the current ISSM president,
Chris G. McMahon.
The Need for an Evidence-Based Definition of
Acquired Premature Ejaculation
The lack of consensus as to what constitutes
acquired PE has continued to hamper clinical
practice and basic and clinical research into the
etiology and management of this condition. The
results of epidemiological and drug treatment
clinical trials on PE are only reliable, interpre-
table, and capable of being generalized to patients
when consistent objective physiological measures
or sensitive, validated outcome assessment instru-
ments are used as study endpoints in well-deﬁned
and consistent populations where lifelong PE,
acquired PE, and PE with comorbid ED are
treated as separate PE subtypes [24].
The original Ad Hoc Committee for the Deﬁ-
nition of Premature Ejaculation concluded that
there was insufﬁcient published evidence to
propose an evidence-based deﬁnition of acquired
PE [10]. The committee anticipated that future
studies would generate sufﬁcient data to develop
an evidence-based deﬁnition for acquired PE. The
committee suggested that a post hoc review of
baseline data from Phase 3 dapoxetine drug trials
might provide preliminary exploratory data on the
dimensions of acquired PE that might assist in
future research and the development of an
evidence-based deﬁnition for acquired PE. These
data were interpreted as suggesting that men with
acquired PE have similar IELTs and report similar
levels of ejaculatory control and distress to men
with lifelong PE, raising the possibility of a single
unifying deﬁnition of PE [25].
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However, as acquired PE generally manifests
later in life and is likely to have a different etiology
[26], it may be that the presenting patient charac-
teristics and/or symptoms reported by men with
acquired PE differ from those of men with lifelong
PE. Additional information regarding differential
symptomatology and/or sexual history experiences
in men with acquired PE may facilitate the devel-
opment of a deﬁnition and assist in the diagnosis of
acquired PE. A more accurate deﬁnition may
improve design of research and assist in selecting
the best treatments for this PE subtype.
Operationalization of PE Variables and Constructs
The original Ad Hoc Committee for the Deﬁni-
tion of Premature Ejaculation agreed that errors of
PE diagnosis and classiﬁcation can be minimized
by the development and clinical application
of a multivariate deﬁnition that captures and
operationalizes (i.e., develops into an identifying
measure, procedure, or operation) the key PE con-
structs of rapidity of ejaculation, perceived lack of
ejaculatory self-efﬁcacy or control, and negative
personal and interpersonal consequences (e.g.,
distress) [10].
The committee determined that operationa-
lization was inherently difﬁcult and that the
constructs were interrelated and potentially
confounded by each other and by multiple other
variables [10,27]. The following measures were
identiﬁed as adequately but not precisely capturing
the essence of each construct [10,27]:
1. Rapidity of ejaculation (patient estimation or
stopwatch measurement).
2. Perceived ejaculatory control (improvements in
ejaculation latency time during attempts to
delay ejaculation or by the measurement of the
subjective feeling of ejaculatory control using
patient report or validated single-item or multi-
item multidomain PE inventories).
3. Negative personal consequences (patient report
or measurement using validated single-item or
multi-item multidomain PE inventories of
sexual or global levels of distress, bother, frus-
tration, anxiety, depression, conﬁdence, self-
esteem and quality of life).
The ISSM Definition of Lifelong and Acquired PE
Members of the second Ad Hoc Committee for
the Deﬁnition of Premature Ejaculation unani-
mously agreed that lifelong and acquired PE are
distinct and different demographically and etio-
logically. However, they can be jointly deﬁned, in
part, by the constructs of time from penetration
to ejaculation, inability to delay ejaculation, and
negative personal consequences from PE. The
committee agreed that the presence of these
mutual constructs was sufﬁcient justiﬁcation for
the development of a single unifying deﬁnition of
both lifelong and acquired PE. Finally, the com-
mittee determined that the presence of a clinically
signiﬁcant and bothersome reduction in latency
time, often to about 3 minutes or less, was an
additional key deﬁning dimension of acquired PE.
The second ISSM Ad Hoc Committee for the
Deﬁnition of Premature Ejaculation deﬁned PE
(lifelong and acquired) as a male sexual dysfunc-
tion characterized by the following:
1. Ejaculation that always or nearly always occurs
prior to or within about 1 minute of vaginal
penetration (lifelong PE) or a clinically signiﬁ-
cant and bothersome reduction in latency time,
often to about 3 minutes or less (acquired PE).
2. The inability to delay ejaculation on all or
nearly all vaginal penetrations.
3. Negative personal consequences, such as dis-
tress, bother, frustration, and/or the avoidance
of sexual intimacy.
The Committee agreed that published objective
evidence on PE is limited to studies of men with
PE engaging in vaginal intercourse. There is insuf-
ﬁcient information to objectively deﬁne problem-
atic early ejaculation in the context of oral sex, anal
sex, and same-gender sexual activity.
History of Definitions of PE
During the period of 1920 to 1960, the absence of
any scientiﬁc publications proposing a deﬁnition
of PE reﬂects the scarcity of prevalence data.
Based upon the limited published literature, a man
was considered to suffer from PE when he ejacu-
lated within seconds or within about a minute of
vaginal penetration [28]. In the 1970s, despite an
absence of any empirical data, Masters and
Johnson rejected this ejaculation latency proposal
and deﬁned PE as a man’s inability to satisfy his
female partner in more than 50% of sexual events
[1]. In spite of their noteworthy accomplishments,
Masters and Johnson’s deﬁnition was seriously
ﬂawed in that the diagnosis was determined by the
female partner’s response rather than the sexual
function of the man. Additionally, their rejection
of the ejaculation time criterion has led to a debate
on “objective criteria” and “subjective criteria” for
PE [29]. Typical “objective” criteria include the
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ejaculation latency time and the number of penile
thrusts. “Subjective” criteria are measures of self-
efﬁcacy including “diminished feelings of control”
and “ejaculation at moments without wishing it.”
These opposing constructs have served as the
framework for the development of the various
deﬁnitions proposed in the DSM by the APA
[12,13].
DSM Definitions of PE
The ﬁrst ofﬁcial deﬁnition of PE was established
in 1980 by the APA in the DSM-III [30]. PE was
deﬁned as “ejaculation that occurs before the indi-
vidual wishes it, because of recurrent and persis-
tent absence of reasonable voluntary control of
ejaculation and orgasm during sexual activity”
[30]. However, because of disagreement on the
criterion of “reasonable voluntary control,” this
criterion was removed in the subsequent DSM-
III-R and DSM-IV deﬁnitions [31,32] and
replaced by the criterion of a “short ejaculation
time.” The DSM-IV-TR deﬁned PE as a “persis-
tent or recurrent ejaculation with minimal sexual
stimulation before, on, or shortly after penetration
and before the person wishes it,” stating that “the
clinician must take into account factors that affect
the duration of the excitement phase such as age,
novelty of the sexual partner or situation, and
recent frequency of sexual activity” and requiring
for the diagnosis that “the disturbance causes
marked distress or interpersonal difﬁculty” [32].
As such, the DSM-III deﬁnition involves the cri-
terion of control but not that of time, whereas
subsequent DSM-III-R, DSM-IV, and DSM-
IV-TR deﬁnitions involved the criterion of time
but not that of control [12,13].
DSM-5 Definition of PE
Based upon the same data that supported the
ISSM deﬁnition of lifelong PE, the recently pub-
lished DSM-5 deﬁnition of PE now includes an
objective ejaculatory latency criterion. The
DSM-5 deﬁnes PE by four major criteria [33]:
A. A persistent or recurrent pattern of ejaculation
occurring during partnered sexual activity
within approximately 1 minute following
vaginal penetration and before the person
wishes it.
B. The symptom in Criterion A must have been
present for at least six months and must be
experienced on almost all or all (approximately
75%–100%) occasions of sexual activity (in
identiﬁed situational contexts or if generalized,
in all contexts)
C. The symptom in Criterion A causes clinically
signiﬁcant distress in the individual.
D. The sexual dysfunction is not better explained
by a nonsexual mental disorder or as a conse-
quence of severe relationship distress or other
signiﬁcant stressors and is not attributable to
the effects of a substance/medication or
another medical disorder.
The DSM-5 deﬁnition of PE requires clinicians
to specify whether PE is lifelong or acquired and
whether it is generalized or situational. In addi-
tion, the DSM-5 deﬁnition of PE distinguishes
between mild PE (ejaculation occurring within
approximately 30 seconds to 1 minute of vaginal
penetration), moderate PE (ejaculation occurring
within approximately 15–30 seconds of vaginal
penetration), and severe PE (ejaculation occurring
prior to sexual activity, at the start of sexual activ-
ity, or within approximately 15 seconds of vaginal
penetration).
ICD-10 Definition of PE
The World Health Organization’S 1992 Interna-
tional Classiﬁcation of Diseases (ICD-10) deﬁnes
PE as “the inability to control ejaculation sufﬁ-
ciently for both partners to enjoy sexual interac-
tion” and as “an inability to delay ejaculation
sufﬁciently to enjoy lovemaking, and manifest as
either of the following: (i) occurrence of ejacula-
tion before or very soon after the beginning of
intercourse (if a time limit is required: before or
within 15 seconds of the beginning of intercourse);
and (ii) ejaculation occurs in the absence of sufﬁ-
cient erection to make intercourse possible” [3].
The ICD-10 uses both the criterion of “control”
and that of a “very short” ejaculation time, deﬁn-
ing the latter as a maximum of 15 seconds after
penetration. Although the ICD-10 provides an
objective deﬁnition of PE, evidence to support a
latency cutoff of 15 seconds was not provided
[12,13]. Furthermore, the ICD-10 use of the cri-
terion of ejaculation occurring within 15 seconds
restricts the application of the criterion of control
[12,13].
Classification of PE
In 1943, Schapiro [34] proposed a classiﬁcation of
PE into two types, types B and A. Type B (the
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“sexually hypertonic” or “hypererotic” type) rep-
resented a consistent tendency to ejaculate rapidly
from the ﬁrst act of intercourse, and type A (the
“hypotonic” type) was associated with the devel-
opment of ED. In 1989, Godpodinoff [35]
renamed these types as lifelong (primary) and
acquired (secondary) PE. Over the years, other
attempts to specify subtypes have occurred (e.g.,
global vs. situational PE, PE due to the effect of a
substance, etc.).
Community-based normative IELT research
and observational studies of men with PE demon-
strated that IELTs of less than 1 minute have a low
prevalence of about 2.5% in the general popula-
tion. However, a much higher percentage of
men with IELT greater than 1 minute report PE
[19–21,36].
In order to take account of this disparity,
Waldinger and Schweitzer [13,29] proposed a new
classiﬁcation of PE in which four PE subtypes are
distinguished on the basis of the duration of the
IELT, frequency of complaints, and course in life.
In addition to lifelong PE and acquired PE, this
classiﬁcation includes variable PE and subjective
PE. Men with variable PE occasionally experience
an early ejaculation. It should not be regarded as a
disorder, but as a natural variation of the ejacula-
tion time in men [37]. On the other hand, men
with subjective PE complain of PE while actually
having a normal or even extended ejaculation time
[37]. The complaint of PE in these men is prob-
ably related to psychological and/or cultural
factors. In contrast, the consistent early ejacula-
tions of lifelong PE suggest an underlying
neurobiological functional disturbance, whereas
the early ejaculation of acquired PE is more
related to underlying medical and/or psychologi-
cal and interpersonal causes. Serefoglu et al.
[38,39] conﬁrmed the existence of these four PE
subtypes in a cohort of men in Turkey. Recently,
Zhang et al. [40] and Gao et al. [41], using a
similar methodology, conﬁrmed similar prevalence
rates of the four PE subtypes in China to that
reported by Serefoglu et al. [38,39]. This new clas-
siﬁcation and continued research into the diverse
phenomenology, etiology, and pathogenesis of PE
is expected to provide a better understanding of
the four PE subtypes [29]. Although the etiologies
of lifelong and acquired PE differ, the presence of
shared dimensions such as a lack of ejaculatory
control and the presence of negative personal con-
sequences suggest a potential for a single unifying
deﬁnition of both lifelong and acquired PE. With
continued research into the two other PE sub-
types, variable PE and subjective PE, it may be
appropriate to expand this unifying deﬁnition in
the future.
The Rationale for the ISSM Definition of
Lifelong PE
The multivariate, evidence-based ISSM deﬁnition
of lifelong PE captures the key PE constructs of
ejaculatory latency, perceived ejaculatory control,
and the presence of negative personal conse-
quences from PE [10].
Rationale for Inclusion of Ejaculatory Latency
Operationalization of PE using the length of time
between penetration and ejaculation (IELT) forms
the basis of most current clinical studies on PE
[42]. IELT can be measured by a stopwatch or
estimated (Table 1). Several authors report that
estimated and stopwatch IELT correlate reason-
ably well or are interchangeable in assigning PE
status when estimated IELT is combined with
PROs [44,46].
Several studies suggest that 80–90% of men
seeking treatment for lifelong PE ejaculate within
1 minute [17,22,43]. Waldinger et al. reported
IELTs <30 seconds in 77% and <60 seconds in
90% of 110 men with lifelong PE, with only 10%
ejaculating in between 1 and 2 minutes [17]. These
data are consistent with normative community
IELT data, support the notion that IELTs of less
than 1 minute are statistically abnormal, and
conﬁrm that an IELT cutoff of 1 minute will
capture 80–90% of treatment-seeking men with
lifelong PE [21]. Further qualiﬁcation of this
cutoff to “about 1 minute” affords the clinician
sufﬁcient ﬂexibility to also diagnose PE in the
10–20% of PE-treatment-seeking men who ejacu-
late within 1–2 minutes of penetration without
unnecessarily stigmatizing the remaining 80–90%
of men who ejaculate within 1–2 minutes of
penetration but have no complaints of PE.
Rationale for Inclusion of Perceived
Ejaculatory Control
The ability to prolong sexual intercourse by delay-
ing ejaculation and the subjective feelings of ejacu-
latory control comprise the complex construct of
ejaculatory control. Virtually all men report using
at least one cognitive or behavioral technique to
prolong intercourse and delay ejaculation, with
varying degrees of success, and many young men
reported using multiple different techniques [48].
Voluntary delay of ejaculation is most likely
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exerted either prior to or in the early stages of the
emission phase of the reﬂex but progressively
decreases until the point of ejaculatory inevitabil-
ity [49,50].
Several authors have suggested that an inabi-
lity to voluntarily delay ejaculation deﬁnes PE
(Table 2) [54–57]. Patrick et al. reported ratings of
“very poor” or “poor” for control over ejaculation
in 72% of men with PE, compared to 5% in a
group of normal controls [19]. Lower ratings for
control over ejaculation were associated with
shorter IELT with “poor” or “very poor” control
Table 1 Findings of key publications regarding time to ejaculation in PE
Study Summary of primary findings
Waldinger et al. 1998 [17] • 110 men with lifelong PE whose IELT was measured by the use of a stopwatch
• 40% of men ejaculated within 15 seconds, 70% within 30 seconds, and 90% within 1 minute
McMahon 2002 [22] • 1,346 consecutive men with PE whose IELT was measured by the use of a stopwatch/wristwatch
• 77% of men ejaculated within 1 minute
Waldinger et al. 2007 [43] • 88 men with lifelong PE who self-estimated IELT
• 30% of men ejaculated within 15 seconds, 67% within 30 seconds, and 92% within 1 minute after
penetration
• Only 5% ejaculated between 1 and 2 minutes
Waldinger et al. 2005 [21] • Stopwatch IELT study in a random unselected group of 491 men in 5 countries
• IELT had a positively skewed distribution
• Application of 0.5 and 2.5 percentiles as disease standards; 0.5 percentile equated to an IELT of 0.9
minutes and 2.5 percentile to an IELT of 1.3 minutes
Althof 1995 [44] • IELT estimations for PE men correlate reasonably well with stopwatch-recorded IELT
Pryor et al. 2005 [45] • IELT estimations for PE men correlate reasonably well with stopwatch-recorded IELT
Rosen et al. 2007 [46] • Self estimated and stopwatch IELT as interchangeable
• Combining self-estimated IELT and PROs reliably predicts PE
Porst et al. 2010 [25] • Stopwatch IELT was slightly (but significantly) greater for patients with acquired PE vs. lifelong PE (0.9 vs.
0.7 minutes, P < 0.001)
McMahon et al. 2013 [47] • Stopwatch IELT was significantly greater for patients with acquired PE vs. lifelong PE (0.9 vs. 0.7 minutes,
P < 0.001)
Serefoglu et al. 2010 [38] • Self-estimated IELT was lowest in men with lifelong PE and highest in men with subjective PE
• Lifelong PE: 20.47 ± 28.90 seconds (2–120 seconds); acquired PE: 57.91 ± 38.72 seconds (90–180
seconds); variable PE: 144.17 ± 22.47 seconds (120–180 seconds); subjective PE: 286.67 ± 69.96 seconds
(180–420 seconds); P = 0.001
Zhang et al. 2013 [40] • Self-estimated IELT follows a continuum among the four PE syndromes
• Mean self-estimated IELT of 1.65 ± 0.82 minutes in acquired PE patients
Gao et al. 2013 [41] • Self-estimated IELT follows a continuum among the four PE syndromes
• Mean self-estimated IELT of 1.84 ± 1.02 minutes in acquired PE patients
Table 2 Findings of key publications regarding ejaculatory control in PE
Study Summary of primary findings
Grenier and Byers 1997 [48] • Relatively weak correlation between ejaculatory latency and ejaculatory control (r = 0.31)
• Ejaculatory control and latency are distinct concepts
Grenier and Byers 2001 [51] • Relatively poor correlation between ejaculatory latency and ejaculatory control, sharing only 12% of their
variance, suggesting that these PROs are relatively independent
Waldinger et al. 1998 [17] • Little or no control over ejaculation was reported by 98% of subjects during intercourse
• Weak correlation between ejaculatory control and stopwatch IELT (P = 0.06)
Rowland et al. 2000 [52] • High correlation between measures of ejaculatory latency and control (r = 0.81, P < 0.001)
Patrick et al. 2005 [19] • Men diagnosed with PE had significantly lower mean ratings of control over ejaculation (P < 0.0001)
• 72% of men with PE reported ratings of “very poor” or “poor” for control over ejaculation, compared with
5% in a group of normal controls
• IELT was strongly positively correlated with control over ejaculation for subjects (r = 0.51)
Giuliano et al. 2007 [20] • Men diagnosed with PE had significantly lower mean ratings of control over ejaculation (P < 0.0001)
• “Good” or “very good” control over ejaculation in only 13.2% of PE subjects compared to 78.4% of
non-PE subjects
• Perceived control over ejaculation had a significant effect on intercourse satisfaction and personal
distress
• IELT did not have a direct effect on intercourse satisfaction and had only a small direct effect on
personal distress
Patrick et al. 2007 [53] • Effect of IELT upon satisfaction and distress appears to be mediated via its direct effect upon control
Rosen et al. 2007 [46] • Control over ejaculation and subject-assessed level of personal distress are more influential in
determining PE status than IELT
• Subject reporting “very good” or “good” control over ejaculation is 90.6% less likely to have PE than a
subject reporting “poor” or “very poor” control over ejaculation
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reported by 67.7%, 10.2%, and 6.7% of subjects
with IELT <1 minute, >1 minute, and >2 minutes
respectively. However, Grenier and Byers failed to
demonstrate a strong correlation between ejacula-
tory latency and subjective ejaculatory control
[48,51]. Several authors report that diminished
control is not exclusive to men with PE and that
some men with a brief IELT report adequate
ejaculatory control and vice versa, suggesting that
the dimensions of ejaculatory control and latency
are distinct concepts [19,48,58]. Furthermore,
there is a greater variability in changes in control
compared with IELT in men treated with SSRIs
[59]. Contrary to this, several authors have
reported a moderate correlation between the
IELT and the feeling of ejaculatory control
[19,20,46,52]. Rosen et al. reported that control
over ejaculation, personal distress, and partner dis-
tress were better predictors of PE status than
IELT [46]. In addition, the effect of IELT upon
satisfaction and distress appears to be mediated
via its direct effect upon control [53]. However,
despite conﬂicting data on the relationship
between control and latency, the balance of evi-
dence supports the notion that the inability to
delay ejaculation appears to differentiate men with
PE from men without PE [19,20,60].
Rationale for Inclusion of Negative
Personal Consequences
Several authors have reported an association
between PE and negative psychological outcomes
in men and their female partners (Table 3)
[19,20,60–72]. Patrick et al. reported signiﬁcant
differences in men with and without PE in the
PRO measures of personal distress (64% vs. 4%)
and interpersonal difﬁculty (31% vs. 1%), suggest-
ing that this personal distress has discriminant
validity in differentiating men with and without
PE [19]. The personal and/or interpersonal dis-
tress, bother, frustration, and annoyance that
results from PE may affect men’s quality of life and
partner relationships, their self-esteem, and their
self-conﬁdence, and can act as an obstacle to single
men forming new partner relationships [19,20,60–
72]. McCabe reported that sexually dysfunctional
men, including men with PE, scored lower on all
aspects of intimacy (emotional, social, sexual, rec-
reational, and intellectual) and had lower levels of
satisfaction compared with sexually functional
men (P < 0.001 or P < 0.01) [63]. Rowland et al.
showed that men with PE had signiﬁcantly lower
overall health-related quality of life, total Self-
Esteem and Relationship Questionnaire scores,
and lower conﬁdence and self-esteem compared to
non-PE groups [61]. Men with PE rated their
overall health-related quality of life lower than
men without PE (P ≤ 0.001).
Rationale for Exclusion of Sexual Satisfaction
Men with PE report lower levels of sexual satisfac-
tion compared with men with normal ejaculatory
latency. Patrick et al. reported ratings of “very
poor” or “poor” for sexual satisfaction in 31% of
Table 3 Findings of key publications regarding the negative personal consequences of PE
Study Summary of primary findings
Patrick et al. 2005 [19] • Using the validated Premature Ejaculation Profile, 64% of men in the PE group vs. 4% in the non-PE group
reported personal distress
Giuliano et al. 2007 [20] • On the Premature Ejaculation Profile, 44% of men in the PE group vs. 1% of men in non-PE group reported
personal distress
Rowland et al. 2007 [61] • Men in highly probable PE group reported greater distress vs. men in non-PE group on Premature
Ejaculation Profile scale
• On the Self-Esteem and Relationship Questionnaire, men with highly probable PE had lower mean scores
overall for confidence and self-esteem vs. non PE men
Rowland et al. 2004 [60] • 30.7% of probable PE group, 16.4% of possible PE group, 7.7% of non-PE group found it difficult to relax
and not be anxious about intercourse
Porst et al. 2007 [62] • Depression reported by 20.4% of PE group vs. 12.4% of non-PE group
• Excessive stress in 28% of PE group vs. 19% of non-PE group
• Anxiety in 24% of PE group vs. 13% of non-PE group
McCabe 1997 [63] • Sexually dysfunctional men, including those with PE, scored lower than sexually functional men on all
measures of intimacy on the Psychological and Interpersonal Relationship Scale
Symonds et al. 2003 [64] • 68% reported self-esteem affected by PE; decreased confidence during sexual encounters
• Anxiety reported by 36% (causing PE or because of it)
• Embarrassment and depression also cited as due to PE
Dunn et al. 1999 [65] Strong association of PE with anxiety and depression on the Hospital Depression and Anxiety Scales
Hartmann et al. 2005 [66] 58% of PE group reported partner’s behavior and reaction to PE was positive, and 23% reported it was
negative
Byers et al. 2003 [67] Men with PE and their partners reported slightly negative impact of PE on personal functioning and sexual
relationship but no negative impact on overall relationship
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subjects with PE compared with 1% in a group of
normal controls [19]. However, caution should be
exercised in assigning lower levels of sexual satis-
faction solely to the effect of PE, and contributions
from other difﬁcult-to-quantify issues such as
reduced intimacy, dysfunctional relationships,
poor sexual attraction, and poor communication
should not be ignored. This is supported by the
report of Patrick et al. that despite reduced ratings
for satisfaction with shorter IELTs, a substantial
proportion of men with an IELT <1 minute
report “good” or “very good” satisfaction ratings
(43.7%). The current data are limited but suggest
that sexual satisfaction is of limited use in differ-
entiating PE subjects from non-PE subjects, and
it was not included in the ISSM deﬁnition of
PE [19].
Epidemiology and Pathophysiology of Acquired PE
Prevalence of Acquired PE
The previous lack of a standardized deﬁnition and
speciﬁc operational criteria for PE has limited
evidence-based research into the epidemiology,
pathogenesis, characteristics, dimensions, and psy-
chological burden of this condition. As a result,
different authors report conﬂicting prevalence
rates for PE (Table 4) [7,36–39,64,74,76,79,80,83–
85,87–90,92–95,98,100–105]. There appears to be
a substantial disparity between the incidence of PE
in epidemiological studies, which rely upon either
patient self-report of PE and/or inconsistent and
poorly validated deﬁnitions of PE [19,20,74], and
that suggested by community-based stopwatch
studies of the IELT [21]. Furthermore, few
researchers have focused on the epidemiology and
characteristics of acquired PE.
Data from the Global Study of Sexual Attitudes
and Behaviors (GSSAB), an international survey
investigating the attitudes, behaviors, beliefs, and
sexual satisfaction of 27,500 men and women aged
40–80 years, reported the global prevalence of PE
(based on subject self-report) to be approximately
30% across all age groups [74]. Perception of
“normal” ejaculatory latency varied by country and
differed between patients and their partners [106].
A core limitation of the GSSAB survey stems from
the fact that the youngest participants were aged
40 years, an age when the incidence of PE might
be different from that in younger males [101].
Fasalo et al. reported that 2,658 of 12,558 men
(21.2%) attending a free andrological consulta-
tion self-diagnosed PE, the majority describing
acquired PE (14.8%), with 4.5% describing life-
long PE [78]. In contrast, Serefoglu et al. [38]
reported that the majority of PE treatment-
seeking patients described lifelong PE (62.5%)
rather than acquired PE (16.1%). Similar ﬁndings
were reported by Zhang et al., who found that the
majority of 1,988 Chinese outpatients described
lifelong PE (35.6%) or acquired PE (28.07%) [40].
These data provide evidence that lifelong and
acquired PE patients comprise the majority of the
patients who seek treatment for the complaint of
ejaculating prematurely. In addition, there appears
to be a disparity between the incidence of the
various PE subtypes in the general community
and in men actively seeking treatment for PE
(Table 5).
Consistent with this notion, Serefoglu et al.
subsequently reported an overall PE prevalence of
19.8%, comprising lifelong PE (2.3%), acquired
PE (3.9%), variable PE (8.5%), and subjective PE
(5.1%) [38]. Using similar research methodology,
Gao et al. reported that 25.80% of 3,016 Chinese
men complained of PE, with similar prevalences of
lifelong PE (3.18%), acquired PE (4.84%), vari-
able PE (11.38%), and subjective PE (6.4%) [41].
Of particular interest is the report of Serefoglu
et al. [38] that men with acquired PE were more
likely to seek medical treatment than men with
lifelong PE (26.53% vs. 12.77%). This ﬁnding was
conﬁrmed by Gao et al., who demonstrated that
acquired PE patients were more likely to seek
(17.12% vs. 14.58%) or plan to seek (36.30% vs.
27.08%) treatment for their complaints, compared
with men with lifelong PE [41]. These data
suggest that the prevalence of acquired PE in the
community is approximately 4% among sexually
active adults and that these patients are more likely
to seek medical treatment (Table 5). The reasons
for increased treatment-seeking behavior in men
with acquired PE compared with men with life-
long PE are unclear. It is possible that men with
lifelong PE may reach a degree of accommodation
to their rapid ejaculation, whereas the additional
psychological burden imposed by the bothersome
change in ejaculatory latency in acquired PE may
prompt treatment seeking.
Etiology of Acquired PE
Acquired PE is most commonly due to sexual per-
formance anxiety [66], psychological or relation-
ship problems [66], or ED [77] and is occasionally
due to prostatitis [107], hyperthyroidism [108], or
withdrawal/detoxiﬁcation from prescribed [109]
or recreational drugs [110].
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Psychological and Relationship Problems
Psychological and relationship factors that may
result in acquired PE include the effect of early
experience and sexual conditioning, anxiety, sexual
technique, the frequency of sexual activity, and
psychodynamic factors [71,111]. Several authors
have suggested that anxiety activates the sympa-
thetic nervous system and reduces the ejaculatory
threshold, leading to an earlier emission [54,112].
Hypoactive sexual desire may lead to acquired PE
because of an unconscious desire to abbreviate
unwanted penetration [111]. Similarly, diminished
sexual desire can be a consequence of chronic and
frustrating PE [10]. Female sexual dysfunctions,
such as anorgasmia, hypoactive sexual desire,
sexual aversion, sexual arousal disorders, and
sexual pain disorders such as vaginismus [112],
may also be related to acquired PE.
Comorbid Erectile Dysfunction
Recent data demonstrate that as many as half of
subjects with ED also experience PE [62,78]. Sub-
jects with ED may either require higher levels of
stimulation to achieve an erection or intentionally
“rush” intercourse to prevent early detumescence
of a partial erection, resulting in ejaculation with a
brief latency [9]. This may be compounded by the
presence of high levels of performance anxiety
related to their ED, which serve only to worsen
their prematurity and erectile function.
Prostate Disease
Acute and chronic lower urogenital infection,
prostatodynia, and chronic pelvic pain syndrome
(CPPS) are associated with ED, PE, and painful
ejaculation [113–115]. Several studies report PE as
the main sexual disorder symptom in men with
chronic prostatitis or CPPS, with a prevalence of
26–77% [116]. The pathophysiologic link between
chronic prostatitis, ED, and PE is unknown.
Prostatic inﬂammation may result in altered
sensation and modulation of the ejaculatory
reﬂex, but evidence in support of this hypothesis
is lacking [115–117]. Antibiotic treatment of
microbiologically conﬁrmed bacterial prostatitis in
men with acquired PE resulted in a 2.6-fold
increase in IELT and improved ejaculatory control
in 83.9% of subjects [117].
Hyperthyroidism
The majority of patients with thyroid hormone
disorders experience sexual dysfunction. Studies
suggest a signiﬁcant correlation between PE and
suppressed thyroid-stimulating hormone (TSH)
values in a selected population of andrological and
sexological patients. The 50% prevalence of PE in
men with hyperthyroidism fell to 15% after treat-
ment with thyroid hormone normalization [108].
Hyperthyroidism is relatively rare in men, with a
prevalence of 0.2% reported in a community-
based study, and is more common in men over 60
years of age [118]. It is very uncommon in the
population who present for treatment of PE, and
routine TSH screening is not recommended
unless clinically indicated [119].
Comparison of Characteristics of Acquired PE and
Lifelong PE
Lifelong PE is a syndrome characterized by a
cluster of core symptoms including early ejacula-
tion at nearly every intercourse—within 30–60
seconds in the majority of cases (80%) or in
between 1 and 2 minutes (20%)—with every or
nearly every sexual partner and from the ﬁrst
sexual encounter onwards [17,22]. Acquired PE
differs in that sufferers develop early ejaculation,
which is often situational, after having previously
had normal ejaculation experiences. The main dis-
tinguishing features between the presentations
of these two syndromes are the time of onset of
symptoms and that there is a reduction in previ-
ously normal ejaculatory latency in acquired PE.
Table 5 Distribution of patients with the complaint of PE according to PE syndromes in the general population and
outpatient clinics in Turkey and China
General male population
Study Population (n) Lifelong PE (%) Acquired PE (%) Variable PE (%) Subjective PE (%)
Serefoglu et al. 2011 [39] 2,593 2.3% 3.9% 8.5% 5.1%
Gao et al. 2013 [41] 3,016 3.2% 4.8% 11.4% 6.4%
Outpatient clinic
Study PE patients (n) Lifelong PE (%) Acquired PE (%) Variable PE (%) Subjective PE (%)
Fasolo et al. 2005 [78] 2,658 21.4% 69.8% Not specified: 8.8%
Serefoglu et al. 2010 [38] 261 62.5% 16.1% 14.5% 6.9%
Zhang et al. 2013 [40] 1988 35.7% 28.1% 12.7% 23.5%
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Although men with lifelong and acquired PE
appear to share the dimensions of short ejaculatory
latency, reduced or absent perceived ejaculatory
control, and the presence of negative personal
consequences from PE, they remain distinct and
different demographic and etiological populations
[25].
Demographic Differences Between Lifelong and
Acquired PE
Consistent with the predominant organic etiology
of acquired PE, men with this complaint are
usually older [25,38–41,47,78]. Fasolo et al.
reported that the mean age of men with acquired
PE was greater compared with that of patients
with lifelong PE (50 vs. 39 years) [78]. Both
Serefoglu et al. [38] and Zhang et al. [40] con-
ﬁrmed this ﬁnding that men with acquired PE
were signiﬁcantly older than men with other PE
syndromes.
Porst et al. reported the results of an integrated
analysis of baseline characteristics and treatment
outcomes from Phase 3 dapoxetine trials in men
with acquired or lifelong PE (n = 2,228) who met
the DSM-IV-TR criteria for PE, had an IELT ≤2
minutes in ≥75% of intercourse episodes and had
mild or no ED (International Index of Erectile
Function [IIEF] score ≥21) [25]. Statistical analysis
was limited to comparison of baseline IELT and
Premature Ejaculation Proﬁle responses between
subjects with acquired PE and lifelong PE with or
without ED.
Although formal statistical analysis of baseline
demographics was not reported, a slight age-
related trend was observed. Subjects with acquired
PE, especially those with mild ED, were noted to
be slightly older than men with lifelong PE
(Table 6). This is consistent with the increased
incidence of ED in acquired PE and the epidemi-
ology of ED. Predictably, the overall mean IIEF
domain scores in men with acquired PE were
slightly lower compared with those in men with
lifelong PE. Men with acquired PE appear less
likely to experience early ejaculation during soli-
tary masturbation and are more likely to beneﬁt
from behavioral treatment, consistent with a syn-
drome associated with situational anxiety symp-
toms [25,47]. Porst et al. concluded that with the
exception of time of onset, duration of PE, and
incidence of ED, the characteristics of men with
acquired and lifelong PE were sufﬁciently similar
in terms of demographics, sexual history, and PE
symptomatology to preclude their use in discrimi-
nating between lifelong and acquired PE.
A post hoc analysis of baseline demographic
data from the COUPLE study, a Phase 3 random-
ized clinical trial of the efﬁcacy and safety of
ﬂexible-dose dapoxetine (30/60 mg) in men with
either lifelong or acquired PE and comorbid ED
who were simultaneously and successfully being
treated with a phosphodiesterase type 5 inhibitor
drug (IIEF erectile function score ≥21), also con-
ﬁrmed that men with acquired PE and comorbid
ED were older than men with lifelong PE and
comorbid ED (Table 6) [47].
Differences in Comorbidities Between Lifelong
and Acquired PE
Godpodinoff [35] noted that 81% of secondary
(acquired) PE patients had “demonstrable organic
Table 6 Demographic, IELT, and PRO data from the post hoc analysis of five Phase 3 dapoxetine trials
Parameter
McMahon et al. 2013 [47,120]
Porst et al. 2010 [25]Overall IIEF-EF 21–25 IIEF-EF 25–26
Acquired
PE
Lifelong
PE
Acquired
PE
Lifelong
PE
Acquired
PE
Lifelong
PE
Acquired
PE
Lifelong
PE
Age (years), mean 52.2 45.5 53.3 46.5 51 44.5 41.9 39.7
IELT (min), mean 1.205 0.99 1.26 0.99 1.16 0.99 1.07 0.9
IELT <1 minute 39.5% 57.0% 35% 60% 44% 54% 45% 58%
IELT 1–2 minutes 58.5% 41.5% 64% 38% 53% 45% 55% 41%
Control
Very poor 28.0% 47.5% 23% 44% 33% 51% 35% 47%
Very poor + poor 80.5% 92.5% 81% 93% 80% 92% 90% 94%
Satisfaction
Very poor 16.0% 29.0% 17% 30% 15% 28% 21% 22%
Very poor + poor 52.0% 76.5% 56% 79% 48% 74% 71% 66%
Distress
Quite a bit + extremely 66.0% 83.5% 63% 83% 69% 84% 72% 71%
Interpersonal difficulty
Quite a bit + extremely 37.0% 58.0% 40% 65% 34% 51% 42% 37%
IIEF-EF = International Index of Erectile Function erectile function domain
52 Serefoglu et al.
Sex Med 2014;2:41–59 © 2014 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
causes” for their PE, whereas 18% demonstrated
no organic causes but were involved in disturbed
or triangular relationships. Recent studies have
suggested that in some men neurobiological and
genetic variations could contribute to the
pathophysiology of lifelong PE [26,29,121–123],
but the etiology of acquired PE can be either psy-
chological or organic, the latter etiology com-
monly being associated with other comorbid
diseases [66,77,107–110]. Men with acquired PE
have a higher incidence of ED and other comorbid
diseases, as well as cardiovascular risk factors
[38–41,78].
Serefoglu et al. [39], Zhang et al. [40], and Gao
et al. [41] reported that patients with acquired PE
had a higher mean BMI and a greater incidence of
comorbid diseases, including hypertension, sexual
desire disorder, diabetes mellitus, chronic prosta-
titis, and ED, compared with patients with life-
long, variable, and subjective PE.
Porst et al. reported the presence of comorbid
ED in 15% and 24% of the lifelong and acquired
PE subgroups, respectively [25]. Overall, the
mean IIEF domain scores were similar for the
lifelong and acquired subgroups for erectile func-
tion (27.9 vs. 27.1), orgasmic function (8.9 vs.
8.6), sexual desire (7.7 vs. 7.5), intercourse satis-
faction (8.2 vs. 7.8), and overall satisfaction (5.1
vs. 5.1). Predictably, slightly lower IIEF domain
scores for the orgasmic function, sexual desire,
intercourse satisfaction, and overall satisfaction
domains were observed in men with mild ED.
However, this post hoc analysis has several limi-
tations imposed by the design of the original
Phase 3 studies that restrict additional analysis of
other factors that may have discriminatory rel-
evance. These limitations include (i) the use of
the authority-based DSM-IV-TR to diagnose
PE; (ii) the lack of a standardized method used to
differentiate lifelong and acquired PE; (iii) the
application of IELT selection criteria based upon
normative IELT data for men with lifelong PE,
which may have ﬁltered out more substantial dif-
ferences in average IELT that may exist between
these two subtypes in the general population; and
(iv) the exclusion of men with moderate or severe
ED (IIEF erectile function domain score <21),
chronic prostatitis, or no available information
regarding hyperthyroidism.
The inclusion of men with moderate or severe
ED in the trials comprising the Porst et al. study
[25] might have resulted in a statistically signiﬁ-
cant age trend consistent with the epidemiology of
ED, in which prevalence is known to increase with
age, and statistically different overall IIEF domain
scores. The greater disparity in age between these
two PE subgroups observed in the COUPLE
study, which enrolled men with more severe ED,
supports this speculation [47].
Differences in IELT Between Lifelong and
Acquired PE
Porst et al. reported that both the arithmetic (1.1
vs. 0.9 minute, P < 0.001) and geometric (0.9 vs.
0.7 minute, P < 0.001) mean IELTs were slightly
(but signiﬁcantly) greater for patients with
acquired PE [25]. Several authors have conﬁrmed
this preliminary ﬁnding by demonstrating that
self-estimated IELT is longer in men with
acquired PE compared with those with lifelong PE
[38,40,41,47].
The post hoc analysis of the COUPLE data
conﬁrms a statistically signiﬁcantly longer IELT in
men with acquired PE and comorbid ED com-
pared with men with lifelong PE with comorbid
ED (52.2 years vs. 45.5 years) (Table 6) [47].
Serefoglu et al. [39] reported that self-estimated
IELT was lowest in men with lifelong PE and
highest in men with subjective PE (lifelong PE
20.47 ± 28.90 seconds [2–120 seconds]; acquired
PE 57.91 ± 38.72 seconds [90–180 seconds];
variable PE 144.17 ± 22.47 seconds [120–180
seconds]; subjective PE 286.67 ± 69.96 seconds
[180–420 seconds, P = 0.001]). Gao et al. [41] and
Zhang et al. [40] conﬁrmed that self-estimated
IELT follows a continuum among the four PE
syndromes and reported a mean self-estimated
IELT of 1.65 ± 0.82 minutes and 1.84 ± 1.02
minutes, respectively, in acquired PE patients.
These data suggest 3 minutes as a valid cutoff for
either self-estimated or stopwatch IELT for the
diagnosis of acquired PE.
Differences in PRO Between Lifelong and
Acquired PE
Both Porst et al. [25] and McMahon et al. [47]
reported that the majority of patients with
acquired and lifelong PE, regardless of comorbid
ED, reported perceived control over ejaculation as
“poor” or “very poor,” levels of satisfaction with
intercourse as “fair” or worse, and levels of
personal distress as at least “moderate.” The
COUPLE data demonstrate that men with life-
long PE and comorbid ED have less control, less
satisfaction, more distress, and more interpersonal
difﬁculty than men with acquired PE and
comorbid ED (Table 6) [47,120].
Evidence-Based Unified Definition of PE 53
Sex Med 2014;2:41–59© 2014 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
These ﬁndings conﬂict with the reports of
Patrick et al. [19] and Serefoglu et al. [39], who
observed better satisfaction with sexual intercourse
and less interpersonal difﬁculty in the lifelong PE
subgroup compared with the acquired PE sub-
group. However, caution should be exercised in
assigning lower levels of sexual satisfaction solely
to the effect of PE, and contributions from other
difﬁcult-to-quantify issues such as reduced inti-
macy, dysfunctional relationships, poor sexual
attraction, and poor communication should not be
ignored. This is supported by the report of Patrick
et al. that despite reduced ratings for satisfaction
with shorter IELTs, a substantial proportion of
men with an IELT <1 minute report “good” or
“very good” satisfaction ratings (43.7%).
In conclusion, men with lifelong and acquired
PE appear to share the dimensions of short
ejaculatory latency, reduced or absent perceived
ejaculatory control, and the presence of negative
personal consequences. Although there are limited
published reports, these studies, supported by
expert opinion, suggest that self-estimated IELT
appears higher in men with acquired PE compared
with those with lifelong PE and that a self-
estimated or stopwatch IELT of 3 minutes is a
valid IELT cutoff for diagnosing acquired PE.
Men with acquired PE are older, have higher inci-
dences of ED, comorbid disease, and cardiovascu-
lar risk factors, and report less sexual satisfaction
and more interpersonal difﬁculty compared with
patients with lifelong PE. Further observational
studies in men with acquired PE are required to
validate the 3-minute IELT cutoff and other
patient characteristics.
Conclusion
Although the 2007 ISSM deﬁnition of lifelong PE
represents a major development in the application
of evidence-based methodology in the ﬁeld of
sexual medicine, its application in clinical practice
is restricted by its limitation to men with lifelong
PE. Research into the epidemiology, etiology, fea-
tures, and treatment of acquired PE has been
limited by the lack of an evidenced-based deﬁni-
tion. An urgent need for standardization of the
methodology for observational, intervention, and
intervention preference trials in PE continues to
exist. The lack of an evidence-based deﬁnition
promotes errors of classiﬁcation, resulting in
poorly deﬁned study populations and in less reli-
able and harder-to-interpret data that are difﬁcult
to generalize to patients.
The uniﬁed ISSM deﬁnition of lifelong and
acquired PE represents an evidence-based deﬁni-
tion for these conditions. This deﬁnition should
form the basis for both the ofﬁce diagnosis of life-
long PE and the design of observational and
interventional clinical trials in PE. It is limited to
men engaging in vaginal intercourse because there
are few studies on early ejaculation in the context
of oral sex, anal sex, and same-gender sexual activ-
ity between men.
The evidence suggests that the multivariate
evidence-based uniﬁed ISSM deﬁnition of lifelong
and acquired PE will reduce errors of diagnosis
and classiﬁcation by providing the clinician with a
discriminating diagnostic tool. The IELT cutoff of
about 1 minute captures the 90% of men with
lifelong PE who actively seek treatment and ejacu-
late within 1 minute but also affords the clinician
sufﬁcient ﬂexibility to also diagnose lifelong PE in
the 10% of men seeking treatment for lifelong PE
who ejaculate within 1–2 minutes of penetration.
The Committee reiterated that the 1-minute
IELT cutoff point should not be applied in the
most absolute sense, as about 10% of men seeking
treatment for lifelong PE have IELTs of 1–2
minutes. The phrase “within about 1 minute”
must be interpreted as giving the clinician sufﬁ-
cient ﬂexibility to diagnose PE also in men who
report an IELT as long as 90 seconds. Similarly, a
degree of ﬂexible clinical judgement is key to the
recognition and interpretation of a bothersome
change in ejaculatory latency with reduction of
premorbid latency to ≤3 minutes in men with
acquired PE. Men who report these ejaculatory
latencies but describe adequate control and no per-
sonal negative consequences related to their rapid
ejaculation do not merit the diagnosis of PE.
This deﬁnition intentionally includes a degree
of diagnostic conservatism and ﬂexibility for
several reasons. First, a conservative and ﬂexible
deﬁnition will provide more realistic ﬁgures for
prevalence of the dysfunction. Second, it will help
to establish PE as a bona ﬁde sexual dysfunction
rather than a lifestyle condition where men are
simply seeking to enhance their sexual function.
Third, it will help to ensure greater conﬁdence in
the efﬁcacy of new and existing treatments and
strengthen the likelihood that regulatory agencies
might approve new efﬁcacious and safe com-
pounds for this dysfunction [27].
We wish to thank the ISSM for its leadership in
assembling and encouraging the committee
members in the development of the evidence-
based deﬁnition of lifelong and acquired PE. We
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anticipate that this deﬁnition will promote and
assist further research into the prevalence of both
lifelong and acquired PE, as well as the develop-
ment of new tools and PROs for both the diagno-
sis and assessment of treatment outcomes and the
development of new pharmacological and psycho-
logical treatments.
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